<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thirty patients with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> <z:hpo ids='HP_0003745'>sporadic</z:hpo> type are presented </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of these cases fulfilled the histologic criteria of <z:e sem="disease" ids="C0006413" disease_type="Neoplastic Process" abbrv="BL">Burkitt's tumor</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The age ranged from 2 to 12 years, with a median of 4 years </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001945'>Fever</z:hpo> and chills were the most common symptoms </plain></SENT>
<SENT sid="4" pm="."><plain>The abdomen was the site of initial presentation in more than half of these cases </plain></SENT>
<SENT sid="5" pm="."><plain>Close to one-third of the patients had involvement of the central <z:mp ids='MP_0008912'>nervous</z:mp> system </plain></SENT>
<SENT sid="6" pm="."><plain>Fifty percent of the patients presented with lactic dehydrogenase elevation </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="3" ids="27226">Uric acid</z:chebi> was elevated in close to one-fourth of these patients </plain></SENT>
<SENT sid="8" pm="."><plain>The sonogram was the most useful technique in those instances of abdominal presentation </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were staged according to Ziegler criteria after an initial surgical diagnostic procedure was performed </plain></SENT>
<SENT sid="10" pm="."><plain>None of the patients received radiotherapy to the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> were submitted to a chemotherapy program for 12 months </plain></SENT>
<SENT sid="12" pm="."><plain>Only 26 fitted the criteria of being evaluable </plain></SENT>
<SENT sid="13" pm="."><plain>The duration of remission was from 1 to 144 months, with a median of 18.2 months </plain></SENT>
<SENT sid="14" pm="."><plain>The actuarial survival was 84% at 3 years </plain></SENT>
<SENT sid="15" pm="."><plain>Most of the responders corresponded to Stages A, B, and AR, while Stages C and D had a high mortality rate with elevated lactic dehydrogenase and <z:chebi fb="3" ids="27226">uric acid</z:chebi> levels </plain></SENT>
</text></document>